Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention — Stella

Home/Preeclampsia Severe/LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

View on ClinicalTrials.gov

Recruiting

Back to Preeclampsia Severe trials

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Greece

First Department of Obstetrics and Gynecology, Alexandra Hospital, Athens, Attica

Key details

Phase

Post-approval study

Sponsor

Alexandra Hospital, Athens, Greece

Enrollment target

~100 participants

Started

January 2023

Primary completion

August 2026

Age range

18 Years and older

Sex

Female only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.